Ticker
Recent Transactions
-
Replimune Group, Inc.
$80 Million - Follow-OnJoint Bookrunner
-
Reata Pharmaceuticals, Inc.
$439 Million - Follow-OnJoint Bookrunner
-
89bio, Inc.
$98 Million - Initial Public OfferingJoint Bookrunner
Research
Select Research
-
Life Science Tools and Diagnostics / Liquid Biopsy Insights Series: Assessing Test Performance and Technologies
October 2019
-
REGN / Is REGN Becoming the TIVO of Biopharma? / Outperform
September 2019
-
Medical Supplies and Devices / Survey Highlights Market Share Gain Potential is Real for Spine Robotics Players
August 2019